$27.24
0.20.74%
Last update: 10:04 AM
15 minutes delayed
Comments
Loading...
Tarsus Pharmaceuticals
TARSNASDAQ
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock, Insider Trading Activity
Tarsus Pharmaceuticals: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Tarsus Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Tarsus Pharmaceuticals Inc
Institutional Shares Held
12.031M
Institutional Percentage Held
31.8%
| Jun 20, 2024 | Jeffrey Farrow Attorney-in-Fact | SEE REMARKS | 17.44K | $27.47 | -$286.92K | SELL-OPTIONS | 2490.86% | 18.14K | Jun 17 - Jun 18 | View |
| Mar 19, 2024 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | 8.17K | $30.60 | -$145.84K | SELL-OPTIONS | 17.80% | 54.08K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Bryan Wahl | GENERAL COUNSEL | 7.60K | $30.60 | -$135.74K | SELL-OPTIONS | 22.80% | 40.95K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | 17.86K | $30.60 | -$318.70K | SELL-OPTIONS | 2.13% | 856.56K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | 7.40K | $30.60 | -$132.01K | SELL-OPTIONS | 27.62% | 34.18K | Mar 15 - Mar 18 | View |
| Mar 19, 2024 | Seshadri Neervannan | CHIEF OPERATING OFFICER | 8.37K | $30.60 | -$149.30K | SELL-OPTIONS | 14.83% | 64.77K | Mar 15 - Mar 18 | View |
| Dec 29, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $20.22 | -$161.76K | SELL | -0.94% | 838.70K | Dec 27 | View |
| Dec 22, 2023 | Jose Trevejo | CHIEF MEDICAL OFFICER | -2.25K | $20.00 | -$45.04K | SELL | -50.01% | 2.25K | Dec 20 | View |
| Dec 22, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -40.00K | $20.27 | -$810.62K | SELL | -4.51% | 846.70K | Dec 20 | View |
| Dec 19, 2023 | Andrew Goldberg | DIRECTOR | 1.00K | $18.96 | $18.96K | BUY | 50.00% | 3.00K | Dec 15 | View |
| Dec 01, 2023 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | 15.56K | $16.31 | -$136.27K | SELL-OPTIONS | 138.74% | 26.78K | Nov 29 - Nov 30 | View |
| Dec 01, 2023 | Bryan Wahl | GENERAL COUNSEL | 15.56K | $16.31 | -$136.29K | SELL-OPTIONS | 94.89% | 31.97K | Nov 29 - Nov 30 | View |
| Nov 17, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $18.37 | -$146.93K | SELL | -0.89% | 886.70K | Nov 15 | View |
| Oct 20, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $13.24 | -$105.92K | SELL | -0.89% | 894.70K | Oct 18 | View |
| Oct 06, 2023 | Jose Trevejo | CHIEF MEDICAL OFFICER | -1.60K | $18.00 | -$28.87K | SELL | -26.26% | 4.50K | Oct 05 | View |
| Sep 22, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $17.21 | -$137.68K | SELL | -0.88% | 902.70K | Sep 20 | View |
| Aug 25, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $17.23 | -$137.84K | SELL | -0.87% | 910.70K | Aug 23 | View |
| Aug 17, 2023 | Yeu Elizabeth Lin | DIRECTOR | 9.51K | $16.80 | $159.70K | BUY | 113.71% | 17.87K | Aug 15 | View |
| Jul 21, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -2.40K | $20.05 | -$48.12K | SELL | -4.98% | 45.81K | Jul 19 | View |
| Jul 21, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -103.90K | $20.01 | -$2.08M | SELL | -10.16% | 918.70K | Jul 19 | View |
| Jul 14, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -9.00K | $17.35 | -$156.15K | SELL | -0.87% | 1.02M | Jul 12 | View |
| Jun 23, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $18.63 | -$149.04K | SELL | -0.77% | 1.03M | Jun 21 | View |
| Jun 16, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -9.00K | $18.58 | -$167.22K | SELL | -0.86% | 1.04M | Jun 14 | View |
| Jun 12, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -3.10K | $20.01 | -$62.03K | SELL | -0.30% | 1.04M | Jun 08 | View |
| Jun 12, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -100.00 | $20.00 | -$2.00K | SELL | -0.21% | 48.09K | Jun 08 | View |
| Jun 08, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -4.64K | $19.00 | -$88.23K | SELL | -8.79% | 48.19K | Jun 06 - Jun 07 | View |
| May 19, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $15.90 | -$127.20K | SELL | -0.75% | 1.05M | May 17 | View |
| May 12, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -9.00K | $16.80 | -$151.20K | SELL | -0.84% | 1.06M | May 10 | View |
| May 02, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -10.12K | $15.11 | -$152.93K | SELL | -0.94% | 1.07M | Apr 28 - May 01 | View |
| Apr 25, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -2.31K | $15.03 | -$34.73K | SELL | -0.21% | 1.08M | Apr 21 | View |
| Apr 21, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $14.02 | -$70.10K | SELL | -15.73% | 26.79K | Apr 20 | View |
| Apr 21, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $13.60 | -$108.80K | SELL | -0.73% | 1.08M | Apr 19 | View |
| Mar 23, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -1.00K | $12.55 | -$12.60K | SELL | -3.06% | 31.79K | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Jose Trevejo | CHIEF MEDICAL OFFICER | -1.51K | $12.58 | -$19.03K | SELL | -19.86% | 6.11K | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Seshadri Neervannan | CHIEF OPERATING OFFICER | -1.14K | $12.55 | -$14.32K | SELL | -2.04% | 54.70K | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Bryan Wahl | GENERAL COUNSEL | -1.08K | $12.55 | -$13.53K | SELL | -6.17% | 16.40K | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -2.13K | $12.55 | -$26.67K | SELL | -0.19% | 1.09M | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | -1.00K | $12.55 | -$12.60K | SELL | -8.21% | 11.22K | Mar 21 - Mar 23 | View |
| Mar 23, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -1.08K | $12.55 | -$13.53K | SELL | -2.00% | 52.83K | Mar 21 - Mar 23 | View |
| Mar 21, 2023 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | -649.00 | $12.94 | -$8.40K | SELL | -5.04% | 12.22K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Bryan Wahl | GENERAL COUNSEL | -696.00 | $12.94 | -$9.00K | SELL | -3.83% | 17.48K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Seshadri Neervannan | CHIEF OPERATING OFFICER | -740.00 | $12.94 | -$9.57K | SELL | -1.31% | 55.84K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Jose Trevejo | CHIEF MEDICAL OFFICER | -1.03K | $12.94 | -$13.38K | SELL | -11.95% | 7.62K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -697.00 | $12.94 | -$9.02K | SELL | -1.28% | 53.91K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Mark Holdbrook | V.P., CLINICAL AFFAIRS | -386.00 | $12.94 | -$4.99K | SELL | -10.79% | 3.19K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -649.00 | $12.94 | -$8.40K | SELL | -1.94% | 32.79K | Mar 17 - Mar 20 | View |
| Mar 21, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -1.54K | $12.96 | -$19.90K | SELL | -0.14% | 1.09M | Mar 17 - Mar 20 | View |
| Mar 17, 2023 | Mark Holdbrook | V.P., CLINICAL AFFAIRS | 2.47K | $13.43 | -$2.51K | SELL-OPTIONS | 221.96% | 3.58K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Bryan Wahl | GENERAL COUNSEL | 4.45K | $13.43 | -$4.53K | SELL-OPTIONS | 32.45% | 18.18K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | 4.15K | $13.43 | -$4.20K | SELL-OPTIONS | 47.56% | 12.87K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Jose Trevejo | CHIEF MEDICAL OFFICER | 7.05K | $13.43 | -$6.70K | SELL-OPTIONS | 439.53% | 8.65K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | 4.45K | $13.43 | -$4.51K | SELL-OPTIONS | 8.88% | 54.60K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Seshadri Neervannan | CHIEF OPERATING OFFICER | 4.74K | $13.43 | -$4.79K | SELL-OPTIONS | 9.14% | 56.58K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -851.00 | $13.44 | -$71.40K | SELL | -2.48% | 33.44K | Mar 15 - Mar 16 | View |
| Mar 17, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | 2.51K | $13.76 | -$120.94K | SELL-OPTIONS | 25.72% | 12.26K | Mar 15 - Mar 16 | View |
| Mar 10, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -5.57K | $15.02 | -$83.65K | SELL | -0.51% | 1.09M | Mar 08 - Mar 09 | View |
| Feb 17, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $15.12 | -$75.60K | SELL | -12.73% | 34.29K | Feb 16 | View |
| Feb 17, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $15.28 | -$122.24K | SELL | -0.72% | 1.10M | Feb 15 | View |
| Feb 10, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -9.00K | $15.14 | -$136.26K | SELL | -0.81% | 1.10M | Feb 08 | View |
| Jan 25, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -4.86K | $15.45 | -$75.03K | SELL | -0.43% | 1.11M | Jan 23 | View |
| Jan 24, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -411.00 | $15.00 | -$6.17K | SELL | -0.04% | 1.13M | Jan 06 | View |
| Jan 20, 2023 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $14.56 | -$72.80K | SELL | -11.29% | 39.29K | Jan 19 | View |
| Jan 20, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.24K | $14.57 | -$120.08K | SELL | -0.73% | 1.12M | Jan 18 - Jan 20 | View |
| Jan 13, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -3.90K | $15.11 | -$58.99K | SELL | -0.35% | 1.13M | Jan 11 | View |
| Jan 11, 2023 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -1.63K | $15.16 | -$24.77K | SELL | -0.14% | 1.13M | Jan 09 - Jan 10 | View |
| Dec 22, 2022 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -8.00K | $14.57 | -$116.56K | SELL | -0.70% | 1.13M | Dec 21 | View |
| Dec 20, 2022 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -535.00 | $15.01 | -$8.03K | SELL | -0.05% | 1.14M | Dec 16 | View |
| Dec 16, 2022 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $14.64 | -$73.20K | SELL | -10.14% | 44.29K | Dec 15 | View |
| Dec 16, 2022 | Bobak Azamian | PRESIDENT/CEO AND BOARD CHAIR | -6.42K | $15.08 | -$96.81K | SELL | -0.56% | 1.14M | Dec 14 | View |
| Dec 06, 2022 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | -1.15K | $16.90 | -$19.50K | SELL | -11.68% | 8.72K | Dec 02 | View |
| Dec 06, 2022 | Bryan Wahl | GENERAL COUNSEL | -1.15K | $16.90 | -$19.50K | SELL | -7.76% | 13.72K | Dec 02 | View |
| Dec 01, 2022 | Dianne Whitfield | CHIEF HUMAN RESOURCES OFFICER | 7.90K | $16.62 | -$39.02K | SELL-OPTIONS | 400.61% | 9.88K | Nov 29 - Dec 01 | View |
| Dec 01, 2022 | Bryan Wahl | GENERAL COUNSEL | 7.90K | $16.62 | -$39.02K | SELL-OPTIONS | 113.35% | 14.88K | Nov 29 - Dec 01 | View |
| Nov 18, 2022 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $16.54 | -$82.70K | SELL | -9.21% | 49.29K | Nov 17 | View |
| Nov 18, 2022 | Bobak Azamian | PRESIDENT AND CEO | -8.00K | $16.86 | -$134.85K | SELL | -0.69% | 1.15M | Nov 16 | View |
| Nov 17, 2022 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -6.86K | $17.72 | -$121.51K | SELL | -12.12% | 49.73K | Nov 15 | View |
| Nov 14, 2022 | Bobak Azamian | PRESIDENT AND CEO | -9.00K | $17.87 | -$160.83K | SELL | -0.77% | 1.15M | Nov 09 | View |
| Oct 28, 2022 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $15.92 | -$79.59K | SELL | -8.43% | 54.29K | Oct 20 | View |
| Oct 21, 2022 | Bobak Azamian | PRESIDENT AND CEO | -8.00K | $16.92 | -$135.35K | SELL | -0.68% | 1.16M | Oct 19 | View |
| Oct 14, 2022 | Bobak Azamian | PRESIDENT AND CEO | -9.00K | $15.91 | -$143.19K | SELL | -0.76% | 1.17M | Oct 12 | View |
| Sep 23, 2022 | Bobak Azamian | PRESIDENT AND CEO | -8.00K | $16.31 | -$130.47K | SELL | -0.67% | 1.18M | Sep 21 | View |
| Sep 16, 2022 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $16.03 | -$80.15K | SELL | -7.78% | 59.29K | Sep 15 | View |
| Sep 16, 2022 | Bobak Azamian | PRESIDENT AND CEO | -9.00K | $16.01 | -$144.09K | SELL | -0.75% | 1.19M | Sep 14 | View |
| Sep 16, 2022 | Yeu Elizabeth Lin | DIRECTOR | 18.40K | $16.12 | $296.61K | BUY | ∞ | 6.36K | Sep 14 | View |
| Aug 19, 2022 | Leonard M Greenstein | CHIEF FINANCIAL OFFICER | -5.00K | $16.30 | -$81.50K | SELL | -7.22% | 64.29K | Aug 18 | View |
| Aug 19, 2022 | Bobak Azamian | PRESIDENT AND CEO | -8.00K | $16.59 | -$132.69K | SELL | -0.66% | 1.20M | Aug 17 | View |
| May 09, 2022 | Michael Ackermann | DIRECTOR | 100.00K | $13.50 | $1.35M | BUY | 8.31% | 1.30M | May 05 | View |
| May 05, 2022 | Vivo Capital IX LLCVivo Capital Fund IX LP | 10% OWNER | -5.37K | $12.25 | -$65.83K | SELL | -0.22% | 2.47M | May 05 | View |
| May 04, 2022 | Vivo Capital IX LLCVivo Capital Fund IX LP | 10% OWNER | -512.96K | $13.39 | -$6.87M | SELL | -17.17% | 2.47M | May 02 - May 04 | View |
| Dec 03, 2021 | Michael Ackermann | DIRECTOR | -5.83K | $24.68 | -$143.93K | SELL | -0.48% | 1.20M | Dec 01 | View |
| Dec 03, 2021 | Bobak Azamian | PRESIDENT AND CEO | -5.83K | $24.72 | -$144.17K | SELL | -0.48% | 1.21M | Dec 01 | View |
| Nov 10, 2021 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -1.89K | $28.11 | -$53.10K | SELL | -3.63% | 50.20K | Nov 08 | View |
| Nov 08, 2021 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -111.00 | $28.04 | -$3.11K | SELL | -0.21% | 52.09K | Nov 04 - Nov 05 | View |
| Nov 04, 2021 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | -6.00K | $26.78 | -$160.69K | SELL | -10.31% | 52.20K | Nov 02 | View |
| Nov 03, 2021 | Michael Ackermann | DIRECTOR | -5.83K | $27.82 | -$162.29K | SELL | -0.48% | 1.21M | Nov 01 | View |
| Nov 03, 2021 | Bobak Azamian | PRESIDENT AND CEO | -5.83K | $27.82 | -$162.28K | SELL | -0.48% | 1.21M | Nov 01 | View |
| Oct 14, 2021 | Michael Ackermann | DIRECTOR | -5.63K | $26.27 | -$148.00K | SELL | -0.46% | 1.22M | Oct 12 | View |
| Oct 14, 2021 | Bobak Azamian | PRESIDENT AND CEO | -5.53K | $26.30 | -$145.45K | SELL | -0.45% | 1.22M | Oct 12 | View |
| Oct 12, 2021 | Michael Ackermann | DIRECTOR | -200.00 | $25.03 | -$5.01K | SELL | -0.02% | 1.22M | Oct 08 | View |
| Oct 12, 2021 | Bobak Azamian | PRESIDENT AND CEO | -302.00 | $25.02 | -$7.56K | SELL | -0.02% | 1.22M | Oct 08 | View |
| Sep 14, 2021 | Aziz Mottiwala | CHIEF COMMERCIAL OFFICER | 4.35K | $14.60 | -$8.46K | SELL-OPTIONS | 8.08% | 58.20K | Sep 10 | View |
| Sep 03, 2021 | Michael Ackermann | DIRECTOR | -5.83K | $25.24 | -$147.24K | SELL | -0.48% | 1.22M | Sep 01 | View |
| Sep 03, 2021 | Bobak Azamian | PRESIDENT AND CEO | -5.83K | $25.25 | -$147.30K | SELL | -0.47% | 1.22M | Sep 01 | View |
| Aug 12, 2021 | Michael Ackermann | DIRECTOR | -621.00 | $25.15 | -$15.62K | SELL | -0.05% | 1.23M | Aug 11 | View |
| Aug 12, 2021 | Bobak Azamian | PRESIDENT AND CEO | -2.02K | $25.07 | -$50.64K | SELL | -0.16% | 1.23M | Aug 10 - Aug 11 | View |
| Aug 10, 2021 | Michael Ackermann | DIRECTOR | -3.83K | $25.00 | -$95.72K | SELL | -0.31% | 1.23M | Aug 06 - Aug 09 | View |
| Aug 10, 2021 | Bobak Azamian | PRESIDENT AND CEO | -2.44K | $25.01 | -$61.09K | SELL | -0.20% | 1.23M | Aug 06 - Aug 09 | View |
| Aug 06, 2021 | Michael Ackermann | DIRECTOR | -1.38K | $25.00 | -$34.58K | SELL | -0.11% | 1.23M | Aug 05 | View |
| Aug 06, 2021 | Bobak Azamian | PRESIDENT AND CEO | -1.37K | $25.00 | -$34.25K | SELL | -0.11% | 1.23M | Aug 05 | View |
| Jun 25, 2021 | Vivo Capital IX LLCVivo Capital Fund IX LP | 10% OWNER | -55.68K | $29.79 | -$1.66M | SELL | -1.83% | 2.99M | Jun 23 - Jun 25 | View |
| Jun 25, 2021 | Vivo Capital IX LLCVivo Capital Fund IX LP | 10% OWNER | -201.62K | $29.05 | -$5.86M | SELL | -6.21% | 3.04M | Jun 21 - Jun 22 | View |
| May 07, 2021 | RTW INVESTMENTS LPRODERICK WONG | 10% OWNER | -450.00K | $29.98 | -$13.49M | SELL | -18.27% | 2.01M | May 07 | View |
| Apr 16, 2021 | Vivo Capital IX LLCVivo Capital Fund IX LP | 10% OWNER | -400.00 | $30.37 | -$12.15K | SELL | -0.01% | 3.24M | Apr 14 | View |
| Oct 20, 2020 | Frazier Life Sciences IX LPFHMLS IX LPFHMLS IX LLCJames TopperPatrick Heron | — | 1.92M | $16.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 1.92M | Oct 20 | View |
| Oct 20, 2020 | Jason Tester as Chief Financial Officer of Horowitz Management, Inc., the managing partner of Horowitz Limited Partnership VIII | — | 1.99M | $16.00 | $2.95M | DERIVATIVE CONVERSION | ∞ | 66.17K | Oct 20 | View |
| Oct 20, 2020 | Vivo Capital IX LLCVivo Capital Fund IX LP | — | 3.25M | $16.00 | $4.00M | DERIVATIVE CONVERSION | ∞ | 3.25M | Oct 20 | View |
| Oct 20, 2020 | Jason Tester | — | 1.95M | $16.00 | $2.75M | DERIVATIVE CONVERSION | ∞ | 1.92M | Oct 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.